T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to HER2 Positive
Related studies linked through entity extraction aliases.
Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1